Shamburg News · 8-K filed Nov 16, 2026, 4:30 PM EST

Aethlon Medical Furnishes November 2026 Investor Presentation on North Immunology Merger

AEMD · AETHLON MEDICAL INC

  • Other event
  • Acquisition
  • Financing
  • Materiality: medium

Aethlon Medical, Inc. furnished an updated investor presentation dated November 2026 under Item 7.01, prepared by North Immunology, Inc. in connection with the proposed merger under the September 17, 2026 Merger Agreement. The presentation covers NOR-101, a half-life extended anti-IL-13 x IL-18 bispecific antibody, and includes a pro forma capitalization table and a $180 million PIPE financing reference. The information is furnished, not filed, and no earnings, dividend, split, or officer change is reported.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 7.01, 9.01, accession 0001683168-26-008860.

Written from the filing by Shamburg Markets. Figures are as reported by the company.